Chemoprevention of aerodigestive tract cancers

被引:32
作者
Kim, ES [1 ]
Hong, WK [1 ]
Khuri, FR [1 ]
机构
[1] Univ Texas, MD Anderson Canc Ctr, Houston, TX 77030 USA
来源
ANNUAL REVIEW OF MEDICINE | 2002年 / 53卷
关键词
head and neck cancer; lung cancer; prevention; retinoids; biochemoprevention;
D O I
10.1146/annurev.med.53.082901.104015
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Epithelial cancers are a major worldwide health problem. Since the mid-1970s, advances in multidisciplinary cancer therapeutics have only slightly improved the mortality rate from epithelial malignancies. Chemoprevention is the use of specific natural or synthetic chemical agents to reverse, suppress, or prevent progression to invasive cancer. Chemopreventive medicine is based on translating basic biologic research into clinical chemical interventions, thus attempting to impede carcinogenesis. Its principles build on the concepts of field cancerization (diffuse epithelial injury that results from carcinogen exposure) and multistep carcinogenesis (a stepwise accumulation of cellular and genetic alterations that progress to cancer). Chemoprevention targets the carcinogenic process at earlier and potentially more reversible stages, focusing on the inhibition of one or many steps in the progression towards cancer. Strategies of chemoprevention include primary prevention in groups at high risk, reversal of premalignant lesions, and prevention of second primary tumors.
引用
收藏
页码:223 / 243
页数:21
相关论文
共 96 条
[41]   MULTIPLE PRIMARY-CANCER IN PATIENTS WITH CANCER OF THE HEAD AND NECK - 2ND CANCER OF THE HEAD AND NECK, ESOPHAGUS, AND LUNG [J].
LICCIARDELLO, JTW ;
SPITZ, MR ;
HONG, WK .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1989, 17 (03) :467-476
[42]   2ND MALIGNANT-TUMORS IN HEAD AND NECK SQUAMOUS-CELL CARCINOMA - THE OVERSHADOWING THREAT FOR PATIENTS WITH EARLY-STAGE DISEASE [J].
LIPPMAN, SM ;
HONG, WK .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1989, 17 (03) :691-694
[43]   COMPARISON OF LOW-DOSE ISOTRETINOIN WITH BETA-CAROTENE TO PREVENT ORAL CARCINOGENESIS [J].
LIPPMAN, SM ;
BATSAKIS, JG ;
TOTH, BB ;
WEBER, RS ;
LEE, JJ ;
MARTIN, JW ;
HAYS, GL ;
GOEPFERT, H ;
HONG, WK .
NEW ENGLAND JOURNAL OF MEDICINE, 1993, 328 (01) :15-20
[44]   Randomized phase III intergroup trial of isotretinoin to prevent second primary tumors in stage I non-small-cell lung cancer [J].
Lippman, SM ;
Lee, JJ ;
Karp, DD ;
Vokes, EE ;
Benner, SE ;
Goodman, GE ;
Khuri, FR ;
Marks, R ;
Winn, RJ ;
Fry, W ;
Graziano, SL ;
Gandara, DR ;
Okawara, G ;
Woodhouse, CL ;
Williams, B ;
Perez, C ;
Kim, HW ;
Lotan, R ;
Roth, JA ;
Hong, WK .
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2001, 93 (08) :605-618
[45]   NOT YET STANDARD - RETINOIDS VERSUS 2ND PRIMARY TUMORS [J].
LIPPMAN, SM ;
HONG, WK .
JOURNAL OF CLINICAL ONCOLOGY, 1993, 11 (07) :1204-1207
[46]   BIOMARKERS AS INTERMEDIATE END-POINTS IN CHEMOPREVENTION TRIALS [J].
LIPPMAN, SM ;
LEE, JS ;
LOTAN, R ;
HITTELMAN, W ;
WARGOVICH, MJ ;
HONG, WK .
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1990, 82 (07) :555-560
[47]   LUNG-CANCER AND SMOKING CESSATION - PATTERNS OF RISK [J].
LUBIN, JH ;
BLOT, WJ .
JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1993, 85 (06) :422-423
[48]  
MALAKER K, 1991, CANCER DETECT PREV, V15, P335
[49]   EARLY DETECTION, DIAGNOSIS, AND MANAGEMENT OF ORAL AND OROPHARYNGEAL CANCER [J].
MASHBERG, A ;
SAMIT, AM .
CA-A CANCER JOURNAL FOR CLINICIANS, 1989, 39 (02) :67-88
[50]  
MATHE G, 1982, CANCER DETECT PREV, V5, P461